(PharmaNewsWire.Com, May 13, 2017 ) Publisher's clinical trial report, "Anemia in Chronic Kidney Disease (Renal Anemia) Global Clinical Trials Review, H1, 2017" provides an overview of Anemia in Chronic Kidney Disease (Renal Anemia) clinical trials scenario. This report provides top line data relating to the clinical trials on Anemia in Chronic Kidney Disease (Renal Anemia) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7) , phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials) . Publisher Clinical Trial Reports are generated using Publisher's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
- The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7) , Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level
Table of Contents List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Anemia in Chronic Kidney Disease (Renal Anemia) to Hematological Disorders Clinical Trials 15 Clinical Trials by Phase in G7 Countries 17 Clinical Trials in G7 Countries by Trial Status 18 Clinical Trials by E7 Countries: Proportion of Anemia in Chronic Kidney Disease (Renal Anemia) to Hematological Disorders Clinical Trials 19 Clinical Trials by Phase in E7 Countries 21 Clinical Trials in E7 Countries by Trial Status 22 Clinical Trials by Phase 23 In Progress Trials by Phase 24 Clinical Trials by Trial Status 25 Clinical Trials by End Point Status 26 Subjects Recruited Over a Period of Time 27 Clinical Trials by Sponsor Type 28 Prominent Sponsors 29 Top Companies Participating in Anemia in Chronic Kidney Disease (Renal Anemia) Therapeutics Clinical Trials 31 Prominent Drugs 33 Latest Clinical Trials News on Anemia in Chronic Kidney Disease (Renal Anemia) 34 Mar 30, 2017: Positive Results Published in Nephrology Dialysis Transplantation From Two China Phase 2 Trials of Roxadustat for Treatment of Anemia in Chronic Kidney Disease 34 Mar 28, 2017: Akebia Announces Publication of Phase 2a Results for Vadadustat in Patients with Anemia Related to Chronic Kidney Disease 34 Clinical Trial Profile Snapshots 36 Appendix 217 Abbreviations 217 Definitions 217 Research Methodology 218 Secondary Research 218 About Publisher 219 Contact Us 219 Source 220 Companies Mentioned: F. Hoffmann-La Roche Ltd FibroGen Inc Astellas Pharma Inc Akebia Therapeutics Inc GlaxoSmithKline Plc Takeda Pharmaceutical Company Ltd Japan Tobacco Inc Amgen Inc Bayer AG Pfizer Inc Inquire for Report at http://www.reportsweb.com/inquiry&RW0001775569/buying
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
